Skip to main content

Advertising Disclaimer »

Main menu

  • Journals
    • Pediatrics
    • Hospital Pediatrics
    • Pediatrics in Review
    • NeoReviews
    • AAP Grand Rounds
    • AAP News
  • Authors/Reviewers
    • Submit Manuscript
    • Author Guidelines
    • Reviewer Guidelines
    • Open Access
    • Editorial Policies
  • Content
    • Current Issue
    • Online First
    • Archive
    • Blogs
    • Topic/Program Collections
    • AAP Meeting Abstracts
  • Pediatric Collections
    • COVID-19
    • Racism and Its Effects on Pediatric Health
    • More Collections...
  • AAP Policy
  • Supplements
  • Multimedia
    • Video Abstracts
    • Pediatrics On Call Podcast
  • Subscribe
  • Alerts
  • Careers
  • Other Publications
    • American Academy of Pediatrics

User menu

  • Log in
  • My Cart

Search

  • Advanced search
American Academy of Pediatrics

AAP Gateway

Advanced Search

AAP Logo

  • Log in
  • My Cart
  • Journals
    • Pediatrics
    • Hospital Pediatrics
    • Pediatrics in Review
    • NeoReviews
    • AAP Grand Rounds
    • AAP News
  • Authors/Reviewers
    • Submit Manuscript
    • Author Guidelines
    • Reviewer Guidelines
    • Open Access
    • Editorial Policies
  • Content
    • Current Issue
    • Online First
    • Archive
    • Blogs
    • Topic/Program Collections
    • AAP Meeting Abstracts
  • Pediatric Collections
    • COVID-19
    • Racism and Its Effects on Pediatric Health
    • More Collections...
  • AAP Policy
  • Supplements
  • Multimedia
    • Video Abstracts
    • Pediatrics On Call Podcast
  • Subscribe
  • Alerts
  • Careers

Discover Pediatric Collections on COVID-19 and Racism and Its Effects on Pediatric Health

American Academy of Pediatrics
From the American Academy of PediatricsClinical Report

Health Care Supervision for Children With Williams Syndrome

Colleen A. Morris, Stephen R. Braddock and COUNCIL ON GENETICS
Pediatrics February 2020, 145 (2) e20193761; DOI: https://doi.org/10.1542/peds.2019-3761
Colleen A. Morris
aDepartment of Pediatrics, University of Nevada, Reno, Reno, Nevada; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen R. Braddock
bDivision of Genetics and Genomic Medicine, Department of Pediatrics, School of Medicine, Saint Louis University, St Louis, Missouri
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
aDepartment of Pediatrics, University of Nevada, Reno, Reno, Nevada; and
bDivision of Genetics and Genomic Medicine, Department of Pediatrics, School of Medicine, Saint Louis University, St Louis, Missouri
  • Article
  • Figures & Data
  • Info & Metrics
  • Comments
Loading
Download PDF

Abstract

This set of recommendations is designed to assist the pediatrician in caring for children with Williams syndrome (WS) who were diagnosed by using clinical features and with chromosome 7 microdeletion confirmed by fluorescence in situ hybridization, chromosome microarray, or multiplex ligation-dependent probe amplification. The recommendations in this report reflect review of the current literature, including previously peer-reviewed and published management suggestions for WS, as well as the consensus of physicians and psychologists with expertise in the care of individuals with WS. These general recommendations for the syndrome do not replace individualized medical assessment and treatment.

  • ADHD
  • attention-deficit/hyperactivity disorder
  • SVAS
  • supravalvular aortic stenosis
  • WS
  • Williams syndrome

Williams syndrome (WS), also known as Williams-Beuren syndrome, is caused by a deletion of part of chromosome 7 and is a multisystem disorder that was first identified as a distinct clinical entity in 1961.1 It is present at birth with a prevalence of 1 in 75002 and affects boys and girls equally. Children with WS usually come to the attention of pediatricians during infancy or early childhood. WS is characterized by dysmorphic facies (100%), cardiovascular disease (80%; most commonly supravalvular aortic stenosis [SVAS]), intellectual disability (75%), a characteristic cognitive profile (90%), and idiopathic hypercalcemia (15% to 45%).1,3–7

The deleted portion of chromosome 7q11.23 seen in WS is 1.5 to 1.8 Mb and contains 26 to 28 genes.3,4,8 It includes the ELN gene that codes for the structural protein elastin, which is an important component of the elastic fibers found in the connective tissue of many organs. The ELN deletion explains some of the characteristics of WS, such as some of the facial features, hoarse voice, inguinal hernia, bladder and bowel diverticula, cardiovascular disease, and orthopedic problems. The pathogenesis of other characteristics, such as intellectual disability, is likely attributable to deletion of contiguous genes in the region. Most deletions in the WS region are de novo. Affected individuals have a 50% chance of transmitting the deletion to offspring. A specific inversion polymorphism in this area can be seen in 6% of the general population and in 25% of parents of individuals with WS, indicating that the presence of this inversion may increase the chance of having a child with WS.9 When the deletion includes only the ELN gene, or if the ELN gene contains a mutation or pathogenic variant, the result is the autosomal, dominantly inherited condition SVAS. These individuals do not have WS. Currently, the majority of cases of WS are detected through a chromosomal microarray that is done for developmental disability. Some of these cases do not have the typical deletion seen in WS and have varying phenotypes that may lack some of the most defining features of WS. The term WS is reserved for the individuals who have typical deletions. A medical genetics evaluation is recommended to discuss the clinical manifestations, natural history, and recurrence risks for parents and other family members.

The pediatrician can use knowledge of the clinical manifestations (Table 1) and the natural history of WS to anticipate medical problems and educate the family. The characteristic facial features of WS are a broad forehead, bitemporal narrowness, periorbital fullness, a stellate and/or lacy iris pattern, a short nose with a bulbous nasal tip, a wide mouth, full lips, and mild micrognathia (Fig 1 A and B). Infants have epicanthal folds, full cheeks, and a flat facial profile, whereas older children and adults often have a narrow face and long neck. Young children typically have small, widely spaced teeth; dental malocclusion is common at all ages. Mild prenatal growth deficiency and a postnatal growth rate that is ∼75% of what is normal are consistently observed. Microcephaly is present in one-third of affected individuals.10 Growth parameters should be plotted on WS growth charts11 (Fig 2A–2F). Children with WS typically have decreased fat stores,12 but obesity may become a problem in teenagers and adults.13,14 The recommendations in this report reflect review of the current literature, including previously peer-reviewed and published management suggestions for WS,3,4,13,15 as well as the consensus of physicians and psychologists with expertise in the care of individuals with WS.

View this table:
  • View inline
  • View popup
TABLE 1

Medical Problems in WS by Organ System and Age

FIGURE 1
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 1

A, Infants and young children with WS. Top row (left to right) is as follows: newborn boy, 6-month-old boy, 9-month-old boy, and 1-year-old girl. Bottom row (left to right) is as follows: 2-year-old girl, 4-year-old boy, and 4-year-old girl (front view and profile). B, Children and adults with WS. Top row (left to right) is as follows: 5-year-old girl, 6-year-old boy, and 10-year-old-girl. Bottom row (left to right) is as follows: 14-year-old girl, 23-year-old man, and 34-year-old woman.

FIGURE 2A
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 2A

Height for females with Williams syndrome. Normal curves = dashed lines; affected patients = solid lines. Reprinted with permission from: Saul RA, Geer JS, Seaver LH, Phelan MC, Sweet KM, Mills MS. Growth References: Third Trimester to Adulthood. Greenwood, SC: Greenwood Genetic Center; 1998.

FIGURE 2B
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 2B

Height for males with Williams syndrome. Normal curves = dashed lines; affected patients = solid lines. Reprinted with permission from: Saul RA, Geer JS, Seaver LH, Phelan MC, Sweet KM, Mills MS. Growth References: Third Trimester to Adulthood. Greenwood, SC: Greenwood Genetic Center; 1998.

FIGURE 2C
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 2C

Weight for females with Williams syndrome. Normal curves = dashed lines; affected patients = solid lines. Reprinted with permission from: Saul RA, Geer JS, Seaver LH, Phelan MC, Sweet KM, Mills MS. Growth References: Third Trimester to Adulthood. Greenwood, SC: Greenwood Genetic Center; 1998.

FIGURE 2D
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 2D

Weight for males with Williams syndrome. Normal curves = dashed lines; affected patients = solid lines. Reprinted with permission from: Saul RA, Geer JS, Seaver LH, Phelan MC, Sweet KM, Mills MS. Growth References: Third Trimester to Adulthood. Greenwood, SC: Greenwood Genetic Center; 1998.

FIGURE 2E
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 2E

Head circumference for females with Williams syndrome. Normal curves = dashed lines; affected patients = solid lines. Reprinted with permission from: Saul RA, Geer JS, Seaver LH, Phelan MC, Sweet KM, Mills MS. Growth References: Third Trimester to Adulthood. Greenwood, SC: Greenwood Genetic Center; 1998.

FIGURE 2F
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 2F

Head circumference for males with Williams syndrome. Normal curves = dashed lines; affected patients = solid lines. Reprinted with permission from: Saul RA, Geer JS, Seaver LH, Phelan MC, Sweet KM, Mills MS. Growth References: Third Trimester to Adulthood. Greenwood, SC: Greenwood Genetic Center; 1998.

Cardiovascular

The majority of children with WS have cardiovascular anomalies secondary to elastin arteriopathy, the major source of morbidity and mortality. Although any artery may be narrowed, the most common problem is SVAS, which may worsen over time, particularly in the first 5 years. Progression is more likely if the severity of the stenosis is moderate or severe and presents in infancy or early childhood.16 SVAS is most commonly a discrete hourglass stenosis or may be a long segment stenosis (∼15%).17 Approximately 30% of children with SVAS will require surgical correction.18 The mortality rate is 6% for cardiac surgery or catheterization.19 Peripheral pulmonic stenosis is common in infancy but often improves over time when occurring in isolation. Mitral valve prolapse and aortic insufficiency may occur in adolescents or adults. QTc prolongation has been reported in 13% of individuals.20

Hypertension is present in 50% of people with WS, may occur at any age, and is occasionally associated with renal artery stenosis.21–23 Increased vascular stiffness, which is a risk factor for stroke, is another manifestation of elastin arteriopathy found in both hypertensive and normotensive children and adults with WS.23 Blood pressure measurement in both arms is recommended at well-child visits with use of a manual cuff at the end of the visit to minimize anxiety. Antihypertensive therapy successfully controls hypertension in most patients and also ameliorates vascular stiffness.21,23 Consider cardiology or nephrology referral for hypertension (blood pressure >90th percentile for age and height).24

Patients with WS are at increased risk for myocardial ischemia, acute hemodynamic deterioration, and sudden death because of their cardiovascular anomalies, especially in the setting of sedation and anesthesia.25 Individuals with biventricular outflow tract obstruction are at the greatest risk.19,26 Sudden death in WS (1 per 1000 patient-years)27 may be related to abnormalities of the coronary arteries (ostial or diffuse stenosis or dilatation)28 or biventricular outflow tract obstruction. Because there is an increased risk of adverse events with sedation and aesthesia, recommendations have been developed for management of sedation and anesthesia in individuals with WS.26,29,30

Children with WS should be evaluated by a pediatric cardiologist with experience in treating WS when feasible. The initial evaluation should include 3 limb blood pressures (2 arms and 1 leg); echocardiogram, including Doppler flow studies; and electrocardiogram. Cardiology follow-up should occur frequently (every 3 months) in the first year of life and at least annually through middle childhood with subsequent intervals dictated by the nature and severity of cardiovascular disease. Children who have decreased pulses, bruits, and/or evidence of diffuse thoracic aortic stenosis will require additional cardiovascular imaging studies (computed tomography, magnetic resonance angiography, or cardiac catheterization) to define the anatomy. Because of the increased risk for serious cardiovascular complications surrounding procedures requiring anesthesia, careful perioperative planning, particularly of nonemergency procedures, is recommended with pediatric anesthesiologists who are familiar with WS and work in centers that can provide multidisciplinary support in the event of serious cardiac decompensation during sedation and anesthesia.26,29,30

Hypercalcemia

Idiopathic infantile hypercalcemia may contribute to the presence of extreme irritability, vomiting, constipation, and muscle cramps associated with this condition.6,31 Problems associated with hypercalcemia include dehydration, hypercalciuria, and nephrocalcinosis.32 Symptomatic hypercalcemia is most common in the first 2 years and usually resolves during childhood,3,33 but lifelong abnormalities of calcium and vitamin D metabolism may persist. Individuals with WS in all age groups have higher median calcium levels than controls.32 There is increased calcium absorption from the gut; the cause of the abnormality in calcium metabolism is unknown.14

Serum calcium determination should be obtained every 4 to 6 months until 2 years of age, every 2 years thereafter, and when hypercalcemia is suspected clinically. Parents should be educated regarding the signs and symptoms of hypercalcemia. Children with WS and normocalcemia should have the reference daily intake of calcium,34 and parents should be cautioned not to restrict calcium without medical supervision.31 Infants with hypercalcemia are usually successfully treated with a low-calcium diet and increased water intake under medical and nutritional supervision, and they require more frequent surveillance of calcium concentrations. Serum blood urea nitrogen, creatinine, vitamin D concentrations (25-hydroxyvitamin D and 1,25-dihydroxyvitamin D), and intact parathyroid hormone should be checked if hypercalcemia is present.35 The urine calcium/creatinine ratio in a random spot urine should be obtained at the time of diagnosis and if hypercalcemia is present (Table 2). If hypercalciuria is found, hydration status should be assessed, serum calcium concentration should be measured, dietary calcium intake should be assessed, and renal ultrasonography should be performed to evaluate for nephrocalcinosis. Referral to a pediatric nephrologist and/or pediatric endocrinologist should be considered for management of persistent hypercalcemia, hypercalciuria, or nephrocalcinosis.32 Multivitamin preparations containing vitamin D should be avoided in early childhood, and vitamin D supplementation should be used with caution in older children and adults.4 Approximately 50% of individuals with WS have impaired bone mineral status osteopenia or osteoporosis; the etiology is unknown.1,14

View this table:
  • View inline
  • View popup
TABLE 2

Normal Values for Random Urinary Calcium/Creatinine Ratios

Gastrointestinal

Infants and toddlers with WS often have difficulty feeding (eg, disordered suck and swallow and textural aversion) and may be brought for medical care because there are symptoms of gastroesophageal reflux, colic, or failure to achieve anticipated weight gain.6 Feeding evaluation and therapy may be of benefit for infants having difficulty transitioning to solid foods, for assessment of aspiration risk and dysphagia, and for intervention for failure to gain weight appropriately according to WS growth curves. Feeding gastrostomy tubes are rarely necessary in WS. Obesity may become a problem for older children and adults.13

Chronic constipation is a common lifelong problem and must be aggressively treated. Typical interventions include increasing water and fiber in the diet followed by the addition of osmotic laxative treatment. Complications of constipation include rectal prolapse, hemorrhoids, and intestinal perforation. There is an increased incidence of diverticulitis occurring at a young age in adolescents and adults.36 Abdominal pain is a frequent complaint in both children and adults; potential causes include gastroesophageal reflux, hiatal hernia, constipation, cholecystitis, diverticular disease, and discrete arterial stenosis causing ischemia.37

Genitourinary

Urinary tract malformations are present in 10% of children with WS,38 bladder diverticula are present in 50%,38,39 and a history of urinary tract infection is present in 25%.40 Bladder capacity is reduced and detrusor overactivity is found in 60% of patients,36 leading to urinary frequency in 69% and enuresis.40 Daytime urinary continence is typically achieved by 4 years of age, and nocturnal continence is present in 50% at 10 years of age.6 Children 4 to 12 years of age have a daytime urinary incontinence rate of 18% and nocturnal enuresis rate of 45%, whereas 2.7% of teenagers have daytime incontinence and 13.5% have nocturnal enuresis.41 Ultrasonography of the kidneys and bladder should be completed at the time of diagnosis. Individuals with recurrent urinary tract infections may require additional urologic evaluation. The practitioner should maintain a low threshold for lower urinary tract imaging (voiding cystourethrography) for the evaluation of voiding dysfunction and/or urinary tract infection. Diverticula may lead to both of these symptoms and can be recurrent after surgical repair. Kidney function should be assessed at the time of diagnosis (serum urea nitrogen and creatinine concentrations and urinalysis).

Neurology, Development, Cognition, and Behavior

Neurologic problems include axial hypotonia and peripheral hypertonia with increased deep tendon reflexes in the lower extremities. Signs of cerebellar dysfunction, such as ataxia and tremor, may increase with age.42 Posterior fossa size is reduced in WS, although cerebellar volume is preserved and may contribute to Chiari I malformation in some individuals with WS.43 Symptoms of headache, dizziness, and dysphagia should prompt the clinician to consider a pediatric neurology referral for evaluation for Chiari malformation. Developmental milestones are delayed,6 and children should be referred to an early intervention program for physical, occupational, and speech therapy evaluation and treatment. Hippotherapy referral may be considered; hippotherapy uses equine movement during physical, occupational, and/or speech therapy and addresses problems of balance.44 Although joint laxity is present in young children, joint contractures occur in older children and adults and lead to an awkward gait.45 Nightly stretching range-of-motion exercises are often recommended. Radioulnar synostosis, found in 10% of affected children, does not respond to physiotherapy or surgical intervention.46 Lordosis and kyphosis are common at all ages; 18% have scoliosis.6,47

Children with WS have a unique cognitive and behavioral profile.7,48,49 Cognitive, motor, and language delay are universal, and in 75% of children, intellectual disability is ultimately diagnosed. Children demonstrate a relative strength in language and verbal short-term memory, with a significant weakness in visuospatial construction.7 A detailed psychoeducational evaluation with information provided by the primary care pediatrician to the school regarding the unique cognitive and behavioral profile is important for school-aged children to develop an appropriate educational plan. A referral to a neuropsychologist may be of benefit. Speech and language, physical, and occupational therapies are important for school-aged children.

Behavioral problems may include hypersensitivity to sound, attention-deficit/hyperactivity disorder (ADHD), and nonsocial anxiety.50 Approximately 50% of children with WS will require pharmacologic treatment of ADHD and/or anxiety. Although overfriendliness and an empathetic nature are commonly observed, many individuals have difficulty with emotional regulation.51 In young children who have limited language, there may be symptom overlap with autism spectrum disorder, such as restricted interests and repetitive behaviors.52 A referral for assessment for autism may be considered in those children. Behavioral interventions based on applied behavior analysis may be helpful, and older children benefit from social skills training and training to master daily living skills.48 Adaptive behavior skills in both children and adults are often more impaired than would be expected for IQ.53,54 Adults require vocational training and instruction in community living skills. Mental health problems, most commonly anxiety, are reported in 25% to 75% of adults.13,55

Sleep disorders are common (50% to 65%), including sleep onset delay, frequent awakenings, decreased sleep efficiency, and increased respiratory-related arousals.56,57 An abnormal or absent melatonin peak may explain disturbance of circadian rhythm in some children.58,59 The clinician should discuss appropriate sleep hygiene and consider a sleep study if obstructive sleep apnea is suspected.

Ocular and Auditory

Hyperopia, nasolacrimal duct obstruction, and strabismus are common in WS.60 An ophthalmologic evaluation should be performed at the time of diagnosis with follow-up as necessary. Mild to moderate sensorineural hearing loss is present in 60% of children and 90% of adults.61 Audiologic assessment should be performed between 6 and 12 months of age and repeated annually.61 Recurrent otitis media is common. The use of noise-canceling headphones is helpful to children who have increased sensitivity to sound or specific phobia for loud noises. Earwax buildup is a common problem and may be treated with cerumen-softening drops.13

Dental

Dental problems include microdontia, missing teeth, and localized enamel hypoplasia.62 Poor fine motor skills cause difficulty with maintenance of dental hygiene and increase the risk of dental caries. A dental home should be established by 1 year of age or within 6 months of the eruption of the first tooth. The dental recall interval should be based on caries risk; dental cleaning every 4 months has been recommended.4 Caregivers should be instructed to assist with brushing and flossing. If dental procedures require anesthesia, WS-specific sedation and anesthesia recommendations should be followed.29,30 Dental malocclusion is present in 85% of individuals with WS and responds to orthodontic treatment. An orthodontic assessment should be part of the evaluation in the dental home.

Endocrine

Hypothyroidism is present in 5% to 10% of children33 At a minimum, thyroid function should be assessed at the time of diagnosis, annually for the first 3 years, and every 2 years thereafter. Subclinical hypothyroidism (mild thyroid-stimulating hormone elevation with normal thyroxine [T4]) is present in 30%.63 Puberty often occurs early (18% of girls), but true precocious puberty is rare.64 A gonadotropin-releasing hormone agonist may be used to treat early puberty; treatment in girls successfully delays menarche and results in taller height compared with controls.65 Abnormal glucose tolerance test results have been documented in 60% to 75% of adults with WS with an increased prevalence of type 2 diabetes mellitus.66,67 An oral glucose tolerance test is recommended at 30 years of age and should be repeated every 5 years if results are normal.13

Medical Home and Transition

Establish a medical home with a clear emphasis on continuity of care and the role of the family members as partners in the ongoing management and care of the child. A summary of anticipatory guidance is provided in Table 3. Counsel the family regarding networks of support, such as extended family, friends, clergy, support groups, and community agencies that serve children and adults with disabilities. The diagnosis should be reviewed and discussed with the affected individual in adolescence with referral to support groups for the adolescent (see American Academy of Pediatrics policy statement “Transition of Care Provided for Adolescents With Special Needs”).68

View this table:
  • View inline
  • View popup
TABLE 3

Anticipatory Guidance in WS

Assist in transition to adult care (especially for cardiology care). Many pediatricians feel comfortable continuing to provide primary care well into young adulthood. Pediatricians can educate the adult and family regarding medical management for adults with WS.37 Counseling should be provided regarding sexuality and reproductive issues, and genetic counseling should be provided. Vocational training and social skills training are essential for successful transition to independent functioning within the community for adults.

Lead Authors

Colleen A. Morris, MD

Stephen R. Braddock, MD

Council on Genetics Executive Committee, 2017–2018

Emily Chen, MD, PhD, FAAP, Co-Chairperson

Tracy L. Trotter, MD, FAAP, Co-Chairperson

Susan A. Berry, MD, FAAP

Leah W. Burke, MD, FAAP

Timothy A. Geleske, MD, FAAP

Rizwan Hamid, MD, PhD, FAAP

Robert J. Hopkin, MD, FAAP

Wendy J. Introne, MD, FAAP

Michael J. Lyons, MD, FAAP

Angela E. Scheuerle, MD, FAAP

Joan M. Stoler, MD, FAAP

Former Executive Committee Members

Debra L. Freedenberg, MD, FAAP

Marilyn C. Jones, MD, FAAP

Robert A. Saul, MD, FAAP, Chairperson

Beth Anne Tarini, MD, MS, FAAP

Liaisons

Katrina M. Dipple, MD, PhD – American College of Medical Genetics

Melissa A. Parisi, MD, PhD – Eunice Kennedy Shriver National Institute of Child Health and Human Development

Britton D. Rink, MD – American College of Obstetricians and Gynecologists

Joan A. Scott, MS, CGC – Health Resources and Services Administration, Maternal and Child Health Bureau

Stuart K. Shapira, MD, PhD – Centers for Disease Control and Prevention

Contributors

R. Thomas Collins II, MD – Williams Syndrome Association Professional Advisory Board

Paige Kaplan, MD – Williams Syndrome Association Professional Advisory Board

Beth A. Kozel, MD, PhD – Williams Syndrome Association Professional Advisory Board

Carolyn B. Mervis, PhD – Williams Syndrome Association Professional Advisory Board

Barbara R. Pober, MD – Williams Syndrome Association Professional Advisory Board

Leslie Smoot, MD – Williams Syndrome Association Professional Advisory Board

Jennifer Walton, MD, MPH – Williams Syndrome Association Professional Advisory Board

Staff

Paul Spire

Footnotes

  • Address correspondence to Colleen A Morris, MD, FAAP. Email: cmorris@med.unr.edu
  • Clinical reports from the American Academy of Pediatrics benefit from expertise and resources of liaisons and internal (AAP) and external reviewers. However, clinical reports from the American Academy of Pediatrics may not reflect the views of the liaisons or the organizations or government agencies that they represent.

  • The guidance in this report does not indicate an exclusive course of treatment or serve as a standard of medical care. Variations, taking into account individual circumstances, may be appropriate.

  • All clinical reports from the American Academy of Pediatrics automatically expire 5 years after publication unless reaffirmed, revised, or retired at or before that time.

  • Resources for parents include the following: the Williams Syndrome Association (570 Kirts Boulevard, Suite 223, Troy, MI 48084-4156; phone: 800-806-1871 [toll free] and 248-244-2229; fax: 248-244-2230; e-mail: info{at}williams-syndrome.org; Web site: www.williams-syndrome.org), the Canadian Association of Williams Syndrome (PO Box 26206, Richmond, British Columbia V6Y 3V3, Canada; phone: 604-214-0132; e-mail: cawbc{at}yahoo.com; Web site: caws.sasktelwebhosting.com), and the US National Library of Medicine Genetics Home Reference (Web site: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC385319/).

  • This document is copyrighted and is property of the American Academy of Pediatrics and its Board of Directors. All authors have filed conflict of interest statements with the American Academy of Pediatrics. Any conflicts have been resolved through a process approved by the Board of Directors. The American Academy of Pediatrics has neither solicited nor accepted any commercial involvement in the development of the content of this publication.

  • FINANCIAL DISCLOSURE: The authors have indicated they have no financial relationships relevant to this article to disclose.

  • FUNDING: No external funding.

  • POTENTIAL CONFLICT OF INTEREST: The authors have indicated they have no potential conflicts of interest to disclose.

References

  1. ↵
    1. Williams JC,
    2. Barratt-Boyes BG,
    3. Lowe JB
    . Supravalvular aortic stenosis. Circulation. 1961;24:1311–1318
    OpenUrlAbstract/FREE Full Text
  2. ↵
    1. Strømme P,
    2. Bjørnstad PG,
    3. Ramstad K
    . Prevalence estimation of Williams syndrome. J Child Neurol. 2002;17(4):269–271
    OpenUrlCrossRefPubMed
  3. ↵
    1. Morris CA
    . Williams Syndrome. In: Pagon RA, Adam MP, Ardinger HH, eds., et al. GeneReviews. Seattle, WA: University of Washington, Seattle; 1999:1993–2014
  4. ↵
    1. Pober BR
    . Williams-Beuren syndrome. N Engl J Med. 2010;362(3):239–252
    OpenUrlCrossRefPubMed
    1. Beuren AJ
    . Supravalvular aortic stenosis: a complex syndrome with and without mental retardation. Natl Found March Dimes Birth Defects Orig Art Ser. 1972;8:45–56
    OpenUrl
  5. ↵
    1. Morris CA,
    2. Demsey SA,
    3. Leonard CO,
    4. Dilts C,
    5. Blackburn BL
    . Natural history of Williams syndrome: physical characteristics. J Pediatr. 1988;113(2):318–326
    OpenUrlCrossRefPubMed
  6. ↵
    1. Mervis CB,
    2. Robinson BF,
    3. Bertrand J,
    4. Morris CA,
    5. Klein-Tasman BP,
    6. Armstrong SC
    . The Williams syndrome cognitive profile. Brain Cogn. 2000;44(3):604–628
    OpenUrlCrossRefPubMed
  7. ↵
    1. Ewart AK,
    2. Morris CA,
    3. Atkinson D, et al
    . Hemizygosity at the elastin locus in a developmental disorder, Williams syndrome. Nat Genet. 1993;5(1):11–16
    OpenUrlCrossRefPubMed
  8. ↵
    1. Hobart HH,
    2. Morris CA,
    3. Mervis CB, et al
    . Inversion of the Williams syndrome region is a common polymorphism found more frequently in parents of children with Williams syndrome. Am J Med Genet C Semin Med Genet. 2010;154C(2):220–228
    OpenUrl
  9. ↵
    1. Pankau R,
    2. Partsch CJ,
    3. Neblung A,
    4. Gosch A,
    5. Wessel A
    . Head circumference of children with Williams-Beuren syndrome. Am J Med Genet. 1994;52(3):285–290
    OpenUrlCrossRefPubMed
  10. ↵
    1. Saul RA,
    2. Stevenson RE,
    3. Rogers RC,
    4. Skinner SA,
    5. Prouty LA,
    6. Flannery DB
    . Williams syndrome. In: Proceedings of the Greenwood Genetic Center. Greenwood, SC: Greenwood Genetic Center; 1988:204–209
  11. ↵
    1. Nogueira RJ,
    2. Zimmerman LF,
    3. Moreno YM, et al
    . Anthropometric and body-mass composition suggests an intrinsic feature in Williams-Beuren syndrome. Rev Assoc Med Bras (1992). 2011;57(6):681–685
    OpenUrlPubMed
  12. ↵
    1. Cherniske EM,
    2. Carpenter TO,
    3. Klaiman C, et al
    . Multisystem study of 20 older adults with Williams syndrome. Am J Med Genet A. 2004;131(3):255–264
    OpenUrlPubMed
  13. ↵
    1. Stagi S,
    2. Manoni C,
    3. Scalini P, et al
    . Bone mineral status and metabolism in patients with Williams-Beuren syndrome. Hormones (Athens). 2016;15(3):404–412
    OpenUrl
  14. ↵
    1. Committee on Genetics
    . American Academy of Pediatrics: health care supervision for children with Williams syndrome. [published correction appears in Pediatrics. 2002;109(2):329]. Pediatrics. 2001;107(5):1192–1204
    OpenUrlAbstract/FREE Full Text
  15. ↵
    1. Collins RT II,
    2. Kaplan P,
    3. Somes GW,
    4. Rome JJ
    . Long-term outcomes of patients with cardiovascular abnormalities and Williams syndrome. Am J Cardiol. 2010;105(6):874–878
    OpenUrlCrossRefPubMed
  16. ↵
    1. Collins RT II
    . Cardiovascular disease in Williams syndrome. Circulation. 2013;127(21):2125–2134
    OpenUrlFREE Full Text
  17. ↵
    1. Kececioglu D,
    2. Kotthoff S,
    3. Vogt J
    . Williams-Beuren syndrome: a 30-year follow-up of natural and postoperative course. Eur Heart J. 1993;14(11):1458–1464
    OpenUrlCrossRefPubMed
  18. ↵
    1. Pham PP,
    2. Moller JH,
    3. Hills C,
    4. Larson V,
    5. Pyles L
    . Cardiac catheterization and operative outcomes from a multicenter consortium for children with Williams syndrome. Pediatr Cardiol. 2009;30(1):9–14
    OpenUrlCrossRefPubMed
  19. ↵
    1. Collins RT II,
    2. Aziz PF,
    3. Gleason MM,
    4. Kaplan PB,
    5. Shah MJ
    . Abnormalities of cardiac repolarization in Williams syndrome. Am J Cardiol. 2010;106(7):1029–1033
    OpenUrlCrossRefPubMed
  20. ↵
    1. Bouchireb K,
    2. Boyer O,
    3. Bonnet D, et al
    . Clinical features and management of arterial hypertension in children with Williams-Beuren syndrome. Nephrol Dial Transplant. 2010;25(2):434–438
    OpenUrlCrossRefPubMed
    1. Del Campo M,
    2. Antonell A,
    3. Magano LF, et al
    . Hemizygosity at the NCF1 gene in patients with Williams-Beuren syndrome decreases their risk of hypertension. Am J Hum Genet. 2006;78(4):533–542
    OpenUrlCrossRefPubMed
  21. ↵
    1. Kozel BA,
    2. Danback JR,
    3. Waxler JL, et al
    . Williams syndrome predisposes to vascular stiffness modified by antihypertensive use and copy number changes in NCF1. Hypertension. 2014;63(1):74–79
    OpenUrlCrossRef
  22. ↵
    1. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents
    . The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004;114(2 ,suppl 4th report):555–576
    OpenUrlCrossRefPubMed
  23. ↵
    1. Bird LM,
    2. Billman GF,
    3. Lacro RV, et al
    . Sudden death in Williams syndrome: report of ten cases. J Pediatr. 1996;129(6):926–931
    OpenUrlCrossRefPubMed
  24. ↵
    1. Latham GJ,
    2. Ross FJ,
    3. Eisses MJ,
    4. Richards MJ,
    5. Geiduschek JM,
    6. Joffe DC
    . Perioperative morbidity in children with elastin arteriopathy. Paediatr Anaesth. 2016;26(9):926–935
    OpenUrl
  25. ↵
    1. Wessel A,
    2. Gravenhorst V,
    3. Buchhorn R,
    4. Gosch A,
    5. Partsch CJ,
    6. Pankau R
    . Risk of sudden death in the Williams-Beuren syndrome. Am J Med Genet A. 2004;127A(3):234–237
    OpenUrl
  26. ↵
    1. Ergul Y,
    2. Nisli K,
    3. Kayserili H, et al
    . Evaluation of coronary artery abnormalities in Williams syndrome patients using myocardial perfusion scintigraphy and CT angiography. Cardiol J. 2012;19(3):301–308
    OpenUrlPubMed
  27. ↵
    1. Burch TM,
    2. McGowan FX Jr.,
    3. Kussman BD,
    4. Powell AJ,
    5. DiNardo JA
    . Congenital supravalvular aortic stenosis and sudden death associated with anesthesia: what’s the mystery? Anesth Analg. 2008;107(6):1848–1854
    OpenUrlCrossRefPubMed
  28. ↵
    1. Matisoff AJ,
    2. Olivieri L,
    3. Schwartz JM,
    4. Deutsch N
    . Risk assessment and anesthetic management of patients with Williams syndrome: a comprehensive review. Paediatr Anaesth. 2015;25(12):1207–1215
    OpenUrlCrossRefPubMed
  29. ↵
    1. Martin ND,
    2. Snodgrass GJ,
    3. Cohen RD
    . Idiopathic infantile hypercalcaemia–a continuing enigma. Arch Dis Child. 1984;59(7):605–613
    OpenUrlAbstract/FREE Full Text
  30. ↵
    1. Sindhar S,
    2. Lugo M,
    3. Levin MD, et al
    . Hypercalcemia in patients with Williams-Beuren syndrome. J Pediatr. 2016;178:254–260.e4
    OpenUrl
  31. ↵
    1. Kim YM,
    2. Cho JH,
    3. Kang E, et al
    . Endocrine dysfunctions in children with Williams-Beuren syndrome. Ann Pediatr Endocrinol Metab. 2016;21(1):15–20
    OpenUrl
  32. ↵
    1. Ross AC,
    2. Taylor CL,
    3. Yaktine AL,
    4. Del Valle HB
    , eds. Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: National Academies Press; 2011
  33. ↵
    1. Lameris AL,
    2. Geesing CL,
    3. Hoenderop JG,
    4. Schreuder MF
    . Importance of dietary calcium and vitamin D in the treatment of hypercalcaemia in Williams-Beuren syndrome. J Pediatr Endocrinol Metab. 2014;27(7–8):757–761
    OpenUrl
  34. ↵
    1. Stagi S,
    2. Lapi E,
    3. Chiarelli F,
    4. de Martino M
    . Incidence of diverticular disease and complicated diverticular disease in young patients with Williams syndrome. Pediatr Surg Int. 2010;26(9):943–944
    OpenUrlPubMed
  35. ↵
    1. Pober BR,
    2. Morris CA
    . Diagnosis and management of medical problems in adults with Williams-Beuren syndrome. Am J Med Genet C Semin Med Genet. 2007;145C(3):280–290
    OpenUrl
  36. ↵
    1. Pankau R,
    2. Partsch CJ,
    3. Winter M,
    4. Gosch A,
    5. Wessel A
    . Incidence and spectrum of renal abnormalities in Williams-Beuren syndrome. Am J Med Genet. 1996;63(1):301–304
    OpenUrlCrossRefPubMed
  37. ↵
    1. Sammour ZM,
    2. de Bessa J Jr.,
    3. Hisano M, et al
    . Lower urinary tract symptoms in children and adolescents with Williams-Beuren syndrome. J Pediatr Urol. 2017;13(2):203.e1-203.e6
    OpenUrl
  38. ↵
    1. Sammour ZM,
    2. Gomes CM,
    3. Duarte RJ,
    4. Trigo-Rocha FE,
    5. Srougi M
    . Voiding dysfunction and the Williams-Beuren syndrome: a clinical and urodynamic investigation. J Urol. 2006;175(4):1472–1476
    OpenUrlCrossRefPubMed
  39. ↵
    1. von Gontard A,
    2. Niemczyk J,
    3. Borggrefe-Moussavian S,
    4. Wagner C,
    5. Curfs L,
    6. Equit M
    . Incontinence in children, adolescents and adults with Williams syndrome. Neurourol Urodyn. 2016;35(8):1000–1005
    OpenUrl
  40. ↵
    1. Chapman CA,
    2. du Plessis A,
    3. Pober BR
    . Neurologic findings in children and adults with Williams syndrome. J Child Neurol. 1996;11(1):63–65
    OpenUrlCrossRefPubMed
  41. ↵
    1. Pober BR,
    2. Filiano JJ
    . Association of Chiari I malformation and Williams syndrome. Pediatr Neurol. 1995;12(1):84–88
    OpenUrlCrossRefPubMed
  42. ↵
    1. Giagazoglou P,
    2. Arabatzi F,
    3. Dipla K,
    4. Liga M,
    5. Kellis E
    . Effect of a hippotherapy intervention program on static balance and strength in adolescents with intellectual disabilities. Res Dev Disabil. 2012;33(6):2265–2270
    OpenUrlPubMed
  43. ↵
    1. Kaplan P,
    2. Kirschner M,
    3. Watters G,
    4. Costa MT
    . Contractures in patients with Williams syndrome. Pediatrics. 1989;84(5):895–899
    OpenUrlAbstract/FREE Full Text
  44. ↵
    1. Morris CA,
    2. Carey JC
    . Three diagnostic signs in Williams syndrome. Am J Med Genet Suppl. 1990;6:100–101
    OpenUrlPubMed
  45. ↵
    1. Morris CA,
    2. Pani AM,
    3. Mervis CB,
    4. Rios CM,
    5. Kistler DJ,
    6. Gregg RG
    . Alpha 1 antitrypsin deficiency alleles are associated with joint dislocation and scoliosis in Williams syndrome. Am J Med Genet C Semin Med Genet. 2010;154C(2):299–306
    OpenUrl
  46. ↵
    1. Mervis CB,
    2. John AE
    . Cognitive and behavioral characteristics of children with Williams syndrome: implications for intervention approaches. Am J Med Genet C Semin Med Genet. 2010;154C(2):229–248
    OpenUrlCrossRefPubMed
  47. ↵
    1. Leyfer OT,
    2. Woodruff-Borden J,
    3. Klein-Tasman BP,
    4. Fricke JS,
    5. Mervis CB
    . Prevalence of psychiatric disorders in 4 to 16-year-olds with Williams syndrome. Am J Med Genet B Neuropsychiatr Genet. 2006;141B(6):615–622
    OpenUrl
  48. ↵
    1. Woodruff-Borden J,
    2. Kistler DJ,
    3. Henderson DR,
    4. Crawford NA,
    5. Mervis CB
    . Longitudinal course of anxiety in children and adolescents with Williams syndrome. Am J Med Genet C Semin Med Genet. 2010;154C(2):277–290
    OpenUrl
  49. ↵
    1. Pitts CH,
    2. Klein-Tasman BP,
    3. Osborne JW,
    4. Mervis CB
    . Predictors of specific phobia in children with Williams syndrome. J Intellect Disabil Res. 2016;60(10):1031–1042
    OpenUrl
  50. ↵
    1. Klein-Tasman BP,
    2. Phillips KD,
    3. Lord C,
    4. Mervis CB,
    5. Gallo FJ
    . Overlap with the autism spectrum in young children with Williams syndrome. J Dev Behav Pediatr. 2009;30(4):289–299
    OpenUrlPubMed
  51. ↵
    1. Mervis CB,
    2. Pitts CH
    . Children with Williams syndrome: developmental trajectories for intellectual abilities, vocabulary abilities, and adaptive behavior. Am J Med Genet C Semin Med Genet. 2015;169(2):158–171
    OpenUrl
  52. ↵
    1. Howlin P,
    2. Udwin O
    . Outcome in adult life for people with Williams syndrome– results from a survey of 239 families. J Intellect Disabil Res. 2006;50(pt 2):151–160
    OpenUrlCrossRefPubMed
  53. ↵
    1. Stinton C,
    2. Elison S,
    3. Howlin P
    . Mental health problems in adults with Williams syndrome. Am J Intellect Dev Disabil. 2010;115(1):3–18
    OpenUrlCrossRefPubMed
  54. ↵
    1. Annaz D,
    2. Hill CM,
    3. Ashworth A,
    4. Holley S,
    5. Karmiloff-Smith A
    . Characterisation of sleep problems in children with Williams syndrome. Res Dev Disabil. 2011;32(1):164–169
    OpenUrlCrossRefPubMed
  55. ↵
    1. Mason TB,
    2. Arens R,
    3. Sharman J, et al
    . Sleep in children with Williams syndrome. Sleep Med. 2011;12(9):892–897
    OpenUrlPubMed
  56. ↵
    1. Santoro SD,
    2. Giacheti CM,
    3. Rossi NF,
    4. Campos LM,
    5. Pinato L
    . Correlations between behavior, memory, sleep-wake and melatonin in Williams-Beuren syndrome. Physiol Behav. 2016;159:14–19
    OpenUrl
  57. ↵
    1. Sniecinska-Cooper AM,
    2. Iles RK,
    3. Butler SA,
    4. Jones H,
    5. Bayford R,
    6. Dimitriou D
    . Abnormal secretion of melatonin and cortisol in relation to sleep disturbances in children with Williams syndrome. Sleep Med. 2015;16(1):94–100
    OpenUrl
  58. ↵
    1. Winter M,
    2. Pankau R,
    3. Amm M,
    4. Gosch A,
    5. Wessel A
    . The spectrum of ocular features in the Williams-Beuren syndrome. Clin Genet. 1996;49(1):28–31
    OpenUrlPubMed
  59. ↵
    1. Marler JA,
    2. Sitcovsky JL,
    3. Mervis CB,
    4. Kistler DJ,
    5. Wightman FL
    . Auditory function and hearing loss in children and adults with Williams syndrome: cochlear impairment in individuals with otherwise normal hearing. Am J Med Genet C Semin Med Genet. 2010;154C(2):249–265
    OpenUrl
  60. ↵
    1. Hertzberg J,
    2. Nakisbendi L,
    3. Needleman HL,
    4. Pober B
    . Williams syndrome–oral presentation of 45 cases. Pediatr Dent. 1994;16(4):262–267
    OpenUrlPubMed
  61. ↵
    1. Palacios-Verdú MG,
    2. Segura-Puimedon M,
    3. Borralleras C, et al
    . Metabolic abnormalities in Williams-Beuren syndrome. J Med Genet. 2015;52(4):248–255
    OpenUrlAbstract/FREE Full Text
  62. ↵
    1. Partsch CJ,
    2. Japing I,
    3. Siebert R, et al
    . Central precocious puberty in girls with Williams syndrome. J Pediatr. 2002;141(3):441–444
    OpenUrlCrossRefPubMed
  63. ↵
    1. Spielmann S,
    2. Partsch CJ,
    3. Gosch A,
    4. Pankau R
    . Treatment of central precocious puberty and early puberty with GnRH analog in girls with Williams-Beuren syndrome. J Pediatr Endocrinol Metab. 2015;28(11–12):1363–1367
    OpenUrl
  64. ↵
    1. Pober BR,
    2. Wang E,
    3. Caprio S, et al
    . High prevalence of diabetes and pre-diabetes in adults with Williams syndrome. Am J Med Genet C Semin Med Genet. 2010;154C(2):291–298
    OpenUrlCrossRef
  65. ↵
    1. Masserini B,
    2. Bedeschi MF,
    3. Bianchi V, et al
    . Prevalence of diabetes and pre-diabetes in a cohort of Italian young adults with Williams syndrome. Am J Med Genet A. 2013;161A(4):817–821
    OpenUrl
  66. ↵
    1. American Academy of Pediatrics Committee on Children with Disabilities and Committee on Adolescence
    . Transition of care provided for adolescents with special health care needs. Pediatrics. 1996;98(6, pt 1):1203–1206
    OpenUrlAbstract/FREE Full Text
  • Copyright © 2020 by the American Academy of Pediatrics
PreviousNext
Back to top

Advertising Disclaimer »

In this issue

Pediatrics
Vol. 145, Issue 2
1 Feb 2020
  • Table of Contents
  • Index by author
View this article with LENS
PreviousNext
Email Article

Thank you for your interest in spreading the word on American Academy of Pediatrics.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Health Care Supervision for Children With Williams Syndrome
(Your Name) has sent you a message from American Academy of Pediatrics
(Your Name) thought you would like to see the American Academy of Pediatrics web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Request Permissions
Article Alerts
Log in
You will be redirected to aap.org to login or to create your account.
Or Sign In to Email Alerts with your Email Address
Citation Tools
Health Care Supervision for Children With Williams Syndrome
Colleen A. Morris, Stephen R. Braddock, COUNCIL ON GENETICS
Pediatrics Feb 2020, 145 (2) e20193761; DOI: 10.1542/peds.2019-3761

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Health Care Supervision for Children With Williams Syndrome
Colleen A. Morris, Stephen R. Braddock, COUNCIL ON GENETICS
Pediatrics Feb 2020, 145 (2) e20193761; DOI: 10.1542/peds.2019-3761
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Print
Download PDF
Insight Alerts
  • Table of Contents

Jump to section

  • Article
    • Abstract
    • Cardiovascular
    • Hypercalcemia
    • Gastrointestinal
    • Genitourinary
    • Neurology, Development, Cognition, and Behavior
    • Ocular and Auditory
    • Dental
    • Endocrine
    • Medical Home and Transition
    • Lead Authors
    • Council on Genetics Executive Committee, 2017–2018
    • Former Executive Committee Members
    • Liaisons
    • Contributors
    • Staff
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • Comments

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Shared developmental gait disruptions across two mouse models of neurodevelopmental disorders
  • Google Scholar

More in this TOC Section

  • Recommended Childhood and Adolescent Immunization Schedule: United States, 2021
  • Ethical Considerations in Pediatricians’ Use of Social Media
  • 2021 Recommendations for Preventive Pediatric Health Care
Show more From the American Academy of Pediatrics

Similar Articles

Subjects

  • Current Policy
  • Genetics
    • Genetics
  • AAP Policy Collections by Authoring Entities
    • Council on Genetics

Keywords

  • ADHD
  • attention-deficit/hyperactivity disorder
  • SVAS
  • supravalvular aortic stenosis
  • WS
  • Williams syndrome
  • Journal Info
  • Editorial Board
  • Editorial Policies
  • Overview
  • Licensing Information
  • Authors/Reviewers
  • Author Guidelines
  • Submit My Manuscript
  • Open Access
  • Reviewer Guidelines
  • Librarians
  • Institutional Subscriptions
  • Usage Stats
  • Support
  • Contact Us
  • Subscribe
  • Resources
  • Media Kit
  • About
  • International Access
  • Terms of Use
  • Privacy Statement
  • FAQ
  • AAP.org
  • shopAAP
  • Follow American Academy of Pediatrics on Instagram
  • Visit American Academy of Pediatrics on Facebook
  • Follow American Academy of Pediatrics on Twitter
  • Follow American Academy of Pediatrics on Youtube
  • RSS
American Academy of Pediatrics

© 2021 American Academy of Pediatrics